IMR Press / JIN / Special Issues / 1617167735419

Anti-inflammatory effects of natural and synthetic compounds in neurodegenerative disorders

Submission deadline: 30 June 2022
Special Issue Editors
Panaro Maria Antonietta, MD
Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy
Interests: Inflammation; Neuroinflammation neurodegeneration
Chiara Porro, PhD
Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy
Interests: Flow cytometry; Inflammation; Apoptosis; Cytokines; Cell culture; Cell migration; Immunohistochemistry; Cell proliferation; Inflammatory diseases; Immunofluorescence
Special Issue Information

Dear Colleagues,

Oxidative stress and chronic neuroinflammation are two key pathologic factors in brain aging and many neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD), and multiple sclerosis (MS).
Brain is an immune-privileged organ, since parenchymal cells (i.e., neurons, astrocytes, microglia, and oligodendrocytes) of the CNS are separated from the rest of body by BBB. However, in recent years, substantial evidence shows that the brain itself is fully immune competent due to the participation of microglia and astrocytes in immune response. 
Activated microglia is an abundant source of free radicals in the brain to release excessive harmful ROS and RNS, which in turn stimulate glial activation and innate immunity. Therefore, oxidative stress and neuroinflammation are two concomitant processes in both brain ageing and neurodegenerative diseases.
Phytochemicals or nutraceuticals are proven to be important regulators of brain health and diseases, which can decrease production of proinflammatory cytokines and oxidative damage and exert significant neuroprotective effect in neurodegenerative diseases.
This special issue will focus the role of various natural or synthetic compounds discussing their neuroprotective mechanism and therapeutic implication for neurodegenerative diseases, including the development of strategies for preventing and managing Neurodegenerative diseases that represent a considerable public health concern.

Prof. Dr. Panaro Maria Antonietta and Prof. Dr. Chiara Porro

Guest Editors

Keywords
Neuroprotection
Chemical derivatives
Drug delivery systems
Natural compounds
Neurodegeneration
Neurodegenerative disease
Oxidative Stress Reactive oxygen species
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1900 USD. Submitted manuscripts should be well formatted in good English.

Back to top